This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Genmab A+s. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Sieto Bosgra: Innovator in Antibody Development
Introduction
Sieto Bosgra is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications.
Latest Patents
Sieto Bosgra holds a patent related to antibodies that bind to B7H4. This invention includes bispecific antibodies that target both B7H4 and CD3. The patent also encompasses pharmaceutical compositions that utilize these antibodies, highlighting their potential use in therapeutic and diagnostic procedures, especially in cancer therapy.
Career Highlights
Sieto Bosgra is associated with Genmab AS, a leading biotechnology company focused on the development of innovative antibody-based therapies. His work at Genmab has positioned him as a key player in the advancement of cancer treatment options.
Collaborations
Some of his notable coworkers include Louise Koopman and Patrick Engelberts, who contribute to the collaborative environment at Genmab.
Conclusion
Sieto Bosgra's innovative work in antibody development showcases his commitment to advancing cancer therapies through biotechnology. His contributions are paving the way for new treatment options that could significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile